Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | KDM6B | O15054 | 1/20 | 0.48 |
| ▸ | KDM5C | P41229 | 1/20 | 0.48 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.48 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.48 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.48 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1774230 | 0.88 | EGLN1 (0.59) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28977856 | 0.88 | EGLN1 (0.59) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL321597 | 0.85 | EGLN1 (0.62) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28887 | 0.85 | EGLN1 (0.62) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28832780 | 0.83 | EGLN1 (0.59) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL12927368 | 0.80 | KDM4E (0.44) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28289355 | 0.78 | PHF8 (0.54) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL10936077 | 0.77 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL26967576 | 0.77 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28078303 | 0.74 | KDM4E (0.50) | KDM4EKDM6BKDM5CEGLN1PHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7807711-B2 | Medicinal acidic cannabinoids | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2010-10-05 | — | — | US | disclosed |
| US-20070032544-A1 | MEDICINAL ACIDIC CANNABINOIDS | NEDERLANDSE ORGANISATIE VOOR TOEGEPASTNATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032544-A1 | MEDICINAL ACIDIC CANNABINOIDS | CNR2, CNR1, ARFGEF1 | KDM4E 2138/4885KDM6B 2729/4885KDM5C 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.